CN101212980A - 大环内酯类用于治疗肠炎症的用途 - Google Patents

大环内酯类用于治疗肠炎症的用途 Download PDF

Info

Publication number
CN101212980A
CN101212980A CNA2006800126183A CN200680012618A CN101212980A CN 101212980 A CN101212980 A CN 101212980A CN A2006800126183 A CNA2006800126183 A CN A2006800126183A CN 200680012618 A CN200680012618 A CN 200680012618A CN 101212980 A CN101212980 A CN 101212980A
Authority
CN
China
Prior art keywords
formula
acceptable salt
macrolides
pharmaceutically acceptable
inflammatory bowel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800126183A
Other languages
English (en)
Chinese (zh)
Inventor
M·德尔塔卡
C·布兰迪兹
G·莫拉佐尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Publication of CN101212980A publication Critical patent/CN101212980A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CNA2006800126183A 2005-03-21 2006-03-14 大环内酯类用于治疗肠炎症的用途 Pending CN101212980A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05102244 2005-03-21
EP05102244.0 2005-03-21

Publications (1)

Publication Number Publication Date
CN101212980A true CN101212980A (zh) 2008-07-02

Family

ID=36649815

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800126183A Pending CN101212980A (zh) 2005-03-21 2006-03-14 大环内酯类用于治疗肠炎症的用途

Country Status (12)

Country Link
US (1) US20080249034A1 (https=)
EP (1) EP1868619A1 (https=)
JP (1) JP2008533186A (https=)
CN (1) CN101212980A (https=)
AU (1) AU2006226381B2 (https=)
BR (1) BRPI0614009A2 (https=)
CA (1) CA2601640C (https=)
EA (1) EA012309B1 (https=)
IT (1) ITMI20060460A1 (https=)
MX (1) MX2007011544A (https=)
WO (1) WO2006100195A1 (https=)
ZA (1) ZA200708423B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2343748T3 (es) * 2005-07-06 2010-08-09 Zambon S.P.A. Formas cristalinas de compuestos macrolidos dotados de una actividad antiinflamatoria.
WO2008065636A2 (en) * 2006-12-01 2008-06-05 University College York - National University Of Ireland, Cork Treatment of disease by modulating cf5 protein
KR20240004268A (ko) * 2021-02-26 2024-01-11 팬더릭스 인코포레이티드 안정화된 초유 조성물
CN113209084A (zh) * 2021-05-18 2021-08-06 南开大学 化合物cp0119在制备用于治疗炎性肠病的药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2089219C1 (ru) * 1994-02-22 1997-09-10 Александра Леонидовна Бурмистрова Способ лечения неспецифического язвенного колита
US5712253A (en) * 1996-06-18 1998-01-27 Abbott Laboratories Macrocyclic 13-membered ring derivatives of erythromycins A and B
US6551632B2 (en) * 1997-04-01 2003-04-22 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
HRP20010018A2 (en) * 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
ITMI20040124A1 (it) * 2004-01-29 2004-04-29 Zambon Spa Macrolidi ad attivita' antiinfiammatoria

Also Published As

Publication number Publication date
EA200702036A1 (ru) 2008-02-28
AU2006226381A1 (en) 2006-09-28
ZA200708423B (en) 2009-03-25
CA2601640A1 (en) 2006-09-28
CA2601640C (en) 2013-10-22
WO2006100195A1 (en) 2006-09-28
AU2006226381B2 (en) 2011-09-08
JP2008533186A (ja) 2008-08-21
ITMI20060460A1 (it) 2006-09-22
BRPI0614009A2 (pt) 2011-03-01
EP1868619A1 (en) 2007-12-26
MX2007011544A (es) 2008-03-11
US20080249034A1 (en) 2008-10-09
EA012309B1 (ru) 2009-08-28

Similar Documents

Publication Publication Date Title
ES2982943T3 (es) Métodos para aumentar el crecimiento en sujetos pediátricos con hepatopatía colestásica
US5945411A (en) Chemoprevention of metachronous adenomatous colorectal polyps
US5843929A (en) Chemoprevention of metachronous adenomatous colorectal polyps
JP2587441B2 (ja) 製薬学的組成物
CN101212980A (zh) 大环内酯类用于治疗肠炎症的用途
EP0811376A1 (en) Use of alkanoyl L-carnitines for the manufacture of a medicament for the treatment of chronic inflammatory bowel diseases
CN105079012B (zh) 天麻素在制备防治溃疡性结肠炎的药物或食品中的应用
PT2106258E (pt) Ibuprofeno contra a tosse
CN105899200A (zh) 用于治疗辐射诱发的胃肠道损伤的方法
CN104983728B (zh) 金合欢素在制备防治溃疡性结肠炎的药物或食品中的应用
JP2018108993A (ja) 注腸剤
CN105147661B (zh) 升麻素在制备防治溃疡性结肠炎的药物或食品中的应用
CN101014333A (zh) 包含洛索洛芬的口服组合物
CN105078960A (zh) 芫花素在制备防治溃疡性结肠炎的药物或食品中的应用
US10471005B2 (en) Low dose pharmaceutical composition
ES2357245T3 (es) Inhibidor de los pólipos intestinales.
JP2900056B2 (ja) 非ステロイド抗炎症剤により生じる胃疾患の予防用医薬組成物
CN118178365A (zh) 石斛酚及其组合物在制备预防和/或治疗消化道炎症的药物或功能食品中的应用
CN112704727A (zh) 特利加压素在制备动力性肠梗阻药物中的应用
CN1649590A (zh) 包含拉呋替丁的治疗剂
US20080076827A1 (en) Treatment of Inflammatory Bowel Disease
JP2006117569A (ja) ステロイド依存性あるいはステロイド抵抗性潰瘍性大腸炎治療薬
JP2003119144A (ja) 胆汁酸誘導体を有効成分とする大腸癌予防／治療剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080702